Medmix Net Income Applicable To Common Shares from 2010 to 2026
| MEDX Stock | 11.58 0.14 1.22% |
Net Loss | First Reported 2010-12-31 | Previous Quarter -6.7 M | Current Value -6.3 M | Quarterly Volatility 25.4 M |
Check Medmix AG financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medmix AG's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Interest Income of 1.2 M or Depreciation And Amortization of 53.6 M, as well as many indicators such as Price To Sales Ratio of 0.81, Dividend Yield of 0.0216 or PTB Ratio of 0.9. Medmix financial statements analysis is a perfect complement when working with Medmix AG Valuation or Volatility modules.
Medmix | Net Income Applicable To Common Shares |
The evolution of Net Income Applicable To Common Shares for medmix AG provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Medmix AG compares to historical norms and industry peers.
Latest Medmix AG's Net Income Applicable To Common Shares Growth Pattern
Below is the plot of the Net Income Applicable To Common Shares of medmix AG over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. Medmix AG's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Medmix AG's overall financial position and show how it may be relating to other accounts over time.
| Net Income Applicable To Common Shares | 10 Years Trend |
|
Net Income Applicable To Common Shares |
| Timeline |
Medmix Net Income Applicable To Common Shares Regression Statistics
| Arithmetic Mean | 31,771,353 | |
| Coefficient Of Variation | 79.86 | |
| Mean Deviation | 23,068,997 | |
| Median | 52,200,000 | |
| Standard Deviation | 25,372,766 | |
| Sample Variance | 643.8T | |
| Range | 59.6M | |
| R-Value | (0.88) | |
| Mean Square Error | 159.3T | |
| R-Squared | 0.77 | |
| Slope | (4,403,275) | |
| Total Sum of Squares | 10300.4T |
Medmix Net Income Applicable To Common Shares History
About Medmix AG Financial Statements
Medmix AG investors use historical fundamental indicators, such as Medmix AG's Net Income Applicable To Common Shares, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Medmix AG. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Loss | -6.7 M | -6.3 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Medmix Stock Analysis
When running Medmix AG's price analysis, check to measure Medmix AG's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medmix AG is operating at the current time. Most of Medmix AG's value examination focuses on studying past and present price action to predict the probability of Medmix AG's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medmix AG's price. Additionally, you may evaluate how the addition of Medmix AG to your portfolios can decrease your overall portfolio volatility.